[1] |
Knight-Nanan D, O′Keefe M, Bowell R. Outcome and complications of intraocular lenses in children with cataract. J Cataract Refract Surg,1996,22:730-736.
|
[2] |
Smith SR, Daynes T, Hinckley M, et al. The effect of capsulorhexis size on development of posterior capsule opacification. J Opthalmol,2004,138:521-526.
|
[3] |
Elner SG, Elner VM. The intergrin super family and the eye. Invest Ophthalmol Vis Sci,1996,37:696-701.
|
[4] |
Sponer U, Pieh S, Soleiman A, et al. Upregulation of alphavbeta6 iniegnn, a Potent TGF-beat1 activator, and Posteror, capsule opacification. J Cataract Refract Surg,2005,31:595-606.
|
[5] |
张鸿侃,谭少健,梁浩,等. 去整合素kistrin对人晶状体上皮细胞株凋亡研究的影响. 眼科新进展,2009,29:667-670.
|
[6] |
McAvoy JW, Chamberlain CG. Fibroblast growth factor (FGF) induces different responses in lens epithelial cells depending on its concentration. Development,1989,107:221-228.
|
[7] |
Meacock WR, Spalton DJ, Hollick EJ, et al. Double-masked prospectove ocular safety study of a lens epithelial cell antibody to prevent posterior capsule opacification. J Cataract Refract Surg,2000,26:716-721.
|
[8] |
Mathias RT, Rae JL, Baldo GJ. Physiological properties of the normal lens. Physiol Rev,1997,77:21-50.
|
[9] |
Nishi O, Nishi K, Mano C, et al. The inhibition of lens epithelial cell migration by a discontinuous capsular bend created by a band-shaped circular loop or a capsule-bending ring. Ophthalmic Surg Lasers,1998,29:119-125.
|
[10] |
Cochener B, Pandey S. Nonbiodegradable drug-sustained capsular ring for Prevention of secondary cataract. Part Ⅱ: In vivo evaluation. J Fr Ophtalmol,2003,26:439-452.
|
[11] |
Yamaguchi K, Stell WK. Quantitative analyses by radioimmunoassay of proliferating cell nuclear antigen (PCNA/cyclin) in ocular tissues. Jpn J Ophthalmol,1994,38:24-29.
|
[12] |
Chandler HL, Barden CA, Lu P, et al. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition. Mol Vis,2007,13:677-691.
|